Expression of Plasminogen Activator Inhibitor-1 in Kidney of Diabetic Rats and Its Modulation by Tongxinluo Capsule

朱雄超,范慧,余国友,郑旭宁
DOI: https://doi.org/10.3969/j.issn.1672-1349.2010.08.041
2010-01-01
Abstract:Objective To investigate the expression of plasminogen activator inhibitor(PAI-1) in renal codex of diabetic rats and the effect of Tongxinluo capsule on it.Methods Sprague-Dawley rats were randomly divided into two groups:Streptozotocin induced diabetic model group(n=22,DM group),and control group(n=20,C group).DM group were randomly divided into two subgroups:DMl,DM2,and C group into Cl,C2.The group of DM2 and C2 were treated with Tongxinluo capsule for 5 weeks whereas DMl and C1 were given normal saline.The body weight and the blood sugar in all rats were measured before and after the treatment.The right kidneys of all the rats were removed and weighed,Pal-lmRNA expression in renal codex were measured by RT-PCR and agarose-gel electrophoresis densitometer.Results The levels of blood sugar and kidney-weight/body-weight,and PAI-1 mRNA expression were increased in diabetic rats compared with that in control group.The PAI-1 mRNA expression in renal cortex in DM2 was lower than that in DMl but higher than that in Cl.There were significant difference in other parameters between DMl and DM2,C1 and C2.Conclusion The expression of PAI-1 mRNA in renal cortex of diabetic rats was upregulated and PAI-1 might be play an important role in the occurrence and development of diabetic nephropathy.Tongxinluo capsule could suppress the increased expression of PAI-1 in renal cortex of diabetic rats.
What problem does this paper attempt to address?